Combination of an autophagy inhibitor with immunoadjuvants and an anti-PD-L1 antibody in multifunctional nanoparticles for enhanced breast cancer immunotherapy

BACKGROUND: The application of combination therapy for cancer treatment is limited due to poor tumor-specific drug delivery and the abscopal effect. METHODS: Here, PD-L1- and CD44-responsive multifunctional nanoparticles were developed using a polymer complex of polyethyleneimine and oleic acid (PEI...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Yibin, Wang, Caixia, Wang, Huihui, Zhang, Zhiwei, Yang, Xiaopeng, Dong, Yanming, Ma, Lixin, Luo, Jingwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9615197/
https://www.ncbi.nlm.nih.gov/pubmed/36303207
http://dx.doi.org/10.1186/s12916-022-02614-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9615197/
https://www.ncbi.nlm.nih.gov/pubmed/36303207
http://dx.doi.org/10.1186/s12916-022-02614-8

Ejemplares similares